Table 1.
Seroprevalence of Toxocara canis in children with asthma
Characteristics | N | Positive n (%) | Negative n (%) | χ 2 | Odds ratio |
---|---|---|---|---|---|
Gender | |||||
Girls | 66 | 14 | 52 | p = .1733 | 1.49 (0.63–3.58) |
Boys | 79 | 12 | 67 | ||
Age range | |||||
5–10 | 69 | 11 | 58 | p = .7564 | |
11–17 | 65 | 13 | 52 | ||
ND | 11 | 2 | 9 | ||
Estates | |||||
Mexico City | 113 | 20 | 93 | p = .6899 | |
Mexico State | 18 | 3 | 15 | ||
Guerrero | 4 | 1 | 3 | ||
Hidalgo | 3 | 0 | 3 | ||
Michoacan | 3 | 1 | 2 | ||
Puebla | 1 | 0 | 1 | ||
Queretaro | 1 | 0 | 1 | ||
Sinaloa | 1 | 1 | 0 | ||
ND | 1 | 0 | 1 | ||
Stool analysis | |||||
Faust | 145 | 0 | 145 | ||
Eosinophils | |||||
Eosinophilia | 36 | 7 | 29 | p = .7848 | 1.143 (0.43–2.99) |
Normal | 109 | 19 | 90 | ||
ELISAa | |||||
L3TESb | 145 | 2 | 143 | ||
Kit IgGc | 145 | 9 | 136 | ||
Native IgGd | 145 | 25 | 120 | ||
Native IgGe | 145 | 26 | 119 | ||
GINAf | |||||
Mild intermittent | 44 | 5 | 39 | p = .5874 | |
Mild persistent | 48 | 11 | 37 | ||
Moderate persistent | 49 | 10 | 39 | ||
Severe persistent | 4 | 0 | 4 | ||
Mild intermittent and ACQg | |||||
Controlled | 23 | 1 | 22 | p = .1098 | |
Partially controlled | 15 | 2 | 13 | ||
Not controlled | 6 | 2 | 4 | ||
Mild persistent and ACQ | |||||
Controlled | 20 | 5 | 15 | p = .2906 | |
Partially controlled | 17 | 5 | 12h | ||
Not controlled | 11 | 1 | 10 | ||
Moderate persistent and ACQ | |||||
Controlled | 24 | 6 | 18 | p = .9151 | |
Partially controlled | 12 | 0 | 12 | ||
Not controlled | 13 | 4i | 9 | ||
Severe persistent and ACQ | |||||
Controlled | 1 | 0 | 1 | ||
Partially controlled | 2 | 0 | 2 | ||
Not controlled | 1 | 0 | 1 |
Abbreviations: ACQ, Asthma Control Questionnaire; ELISA, enzyme‐linked immunosorbent assay; IgG, enzyme‐linked immunosorbent assay.
Enzyme‐linked‐immunosorbent assay.
T. canis third‐stage larval antigens.
Commercial kit (IgG).
Native kit (sera without preadsorbed with Ascaris suum antigens).
Native kit (sera preadsorbed with Ascaris suum antigens).
Global Initiative for Asthma.
Asthma Control Questionnaire.
One patient with L3TES and without IgG.
One patient with L3TES and IgG.